Short- and Long-term Outcomes of Robotic vs Laparoscopic Right Colon Cancer: a 10-year Single-center Retrospective Study

June 8, 2024 updated by: Taiyuan Li

the Ethics Committee of the First Affiliated Hospital of Nanchang University

The goal of this observational study is to evaluate the short-term outcomes and long-term outcomes of robot-assisted right colon group for cancer compared to laparoscopic-assisted right colon group. This is a large sample study based on ten years of clinical data. The main question it aims to answer is: What are the advantages of da Vinci robot right hemicolectomy compared to laparoscopic right hemicolectomy, and is there a difference in long-term efficacy between the two methods.

Study Overview

Detailed Description

Colorectal cancer (CRC) is highly prevalent worldwide. In China, CRC ranks high among the population of men and women with cancer. The incidence and mortality rates of CRC are rising quickly in developing countries, and it is the fourth most deadly cancer in the world. In particular, the right colon cancer (RCC) is continuously growing in China, and the early symptoms of RCC are not typical. one of the most useful ways for RCC is surgical is a surgical operation. Along with the development of minimally invasive surgery, the use of laparoscopy for colon cancer is widely accepted and has become one symbolic surgical technology. Studies have demonstrated that laparoscopic colonic surgery is related to reduced pain after operation, shorter rehabilitation time, shorter length of hospital stay, reduced the time of ileus after surgery, and reduced surgical site infection.

Nevertheless, laparoscopic surgery also has its shortcoming, including a limited range of motion, slow learning and growth, and physiological tremor cannot be eliminated.The emergence of robots has broken the inherent disadvantage of laparoscopy. It has achieved similar or better results in previous studies. Based on these advantages, robotic surgery has received much attention from the surgeons. With the first robotic surgery in the field of colon cancer was reported in 2002, there are some studies proved the safety and feasibility by using robot,However, most studies with small sample sizes and with cases at a relatively early stage.

Therefore, the purpose of this study is to compare the short-term and long-term outcomes between RARC and LARC in the treatment of right colon cancer in our center.

Study Type

Observational

Enrollment (Actual)

1879

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The consecutive cases of robotic-assisted or laparoscopic-assisted right colectomy between December 2014 and March 2024. All cases derived from the First Affiliated Hospital of Nanchang University.

Description

Inclusion Criteria:

  1. The age is more than 18 years old and less than or equal to 85 years old
  2. No distant metastasis (including pelvic cavity, peritoneum, liver, lung, brain, bone, distant lymph node metastasis, etc.) is judged by ultrasound, CT, PET-CT, etc
  3. Preoperative colonoscopy showing that the tumor was located in the ileocecal region, ascending colon, hepatic flexure, or transverse colon with pathology showing malignancy
  4. signed informed consent. -

Exclusion Criteria:

  1. multiple primary colorectal cancer
  2. recurrent right colon cancer
  3. preoperative neoadjuvant chemotherapy
  4. emergency surgery for intestinal obstruction, bleeding or perforation
  5. incomplete data and missing follow-up data. -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
robot-assisted right colon group
Robot assisted radical surgery for right colon cancer
Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system
Other Names:
  • Laparoscopic surgical system
laparoscopic-assisted right colon group
Laparoscopic assisted radical surgery for right colon cancer
Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system
Other Names:
  • Laparoscopic surgical system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
overall survival
Time Frame: 5 years after surgery
months
5 years after surgery
disease-free survival
Time Frame: 5 years after surgery
months
5 years after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
operative time
Time Frame: Intraoperative
minutes
Intraoperative
estimation of blood loss
Time Frame: Intraoperative
milliliters
Intraoperative
the rate of postoperative complications
Time Frame: 1 months after surgery
rate
1 months after surgery
number of retrieved lymph nodes
Time Frame: Intraoperative
numbers
Intraoperative
days after postoperative hospital stay
Time Frame: 1 months after surgery
days
1 months after surgery
time to first exhaust
Time Frame: 1 weeks after surgery
hours
1 weeks after surgery
time to liquid diet
Time Frame: 1 weeks after surgery
hours
1 weeks after surgery
the rate of intracorporeal anastomosis
Time Frame: 1 months after surgery
rate
1 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Actual)

March 31, 2024

Study Completion (Actual)

April 30, 2024

Study Registration Dates

First Submitted

May 29, 2024

First Submitted That Met QC Criteria

June 8, 2024

First Posted (Actual)

June 12, 2024

Study Record Updates

Last Update Posted (Actual)

June 12, 2024

Last Update Submitted That Met QC Criteria

June 8, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Access to the database can be obtained from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Cancer

Clinical Trials on Da Vinci Robot Surgical System

Subscribe